Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content
Older woman outside on bicycle.

WHAT TO EXPECT TARGETED DRUG DELIVERY

Targeted drug delivery is a safe, proven, and effective way to manage chronic pain with fewer side effects and lower doses than oral medication.1

WHAT IS TARGETED DRUG DELIVERY?

Targeted drug delivery provides effective pain relief by delivering medication directly to the fluid surrounding the spinal cord via a programmable pump.1,2

POTENTIAL BENEFITS OF TARGETED DRUG DELIVERY

  • Improved ability to function and participate in day-to-day activities3
  • Effective pain relief1,2
  • Less or no need for oral pain medication1,2
  • Fewer side effects compared to oral medication4
  • Patient satisfaction3
  • Personalized — the optional Personal Therapy Manager allows you to manage your own pain therapy by delivering a dose of medication within your doctor’s pre-set limits.
  • Surgically reversible

ADVANTAGES OVER OTHER TREATMENTS FOR CHRONIC PAIN

Caduceus icon
  • Because targeted drug delivery releases small amounts of medication directly to the fluid surrounding your spine, pain can be controlled with a fraction of the oral medication dose.2
  • Most people experience fewer or more tolerable side effects versus oral dosing, such as constipation and drowsiness.4
  • Targeted drug delivery may provide relief when other treatments — like oral medications or injections — have not
  • It does not have to be a permanent procedure like back surgery.
  • The trial serves as a temporary evaluation period before committing to long-term therapy.

FOUR KEY PRODUCTS WORK TOGETHER TO PROVIDE PRECISE PAIN RELIEF

Pump: A programmable pump that accurately delivers medicine per the dosing instructions provided by your physician.

Catheter: A thin, flexible tube that connects to the pump and delivers medication.

Clinician Programmer: A physician uses the tablet to tailor the therapy to best meet your needs.

Personal Therapy Manager: This handheld device prescribed by your physician at time of implant helps you manage unpredictable pain. It allows you to receive an extra dose of pain medication when needed and within physician set limits.

THE JOURNEY

Male patient speaking with female medical professional.

1. TRIAL BEFORE SURGERY

A trial allows you to try targeted drug delivery before you commit to an implant.

LEARN ABOUT THE TRIAL

2. SURGERY

During the surgery, the drug pump is implanted just under the skin of the abdomen.

LEARN ABOUT THE IMPLANT

3. REFILL

At follow up appointments, your physician fills the pump with pain medication. The pump sends the medication through the catheter to the spinal area where pain receptors are located. You return to your physician’s office for more medicine when the pump needs to be refilled.

POSSIBLE RISKS

Surgical complications are possible. Some of these complications may include infection, headache, spinal fluid leak, or paralysis.

Do not have the implant surgery if you have an active infection at the time, or if your body size is too small to hold the drug pump.

Once the device is implanted, device complications or adverse drug events may occur, which could be life threatening or require additional surgery to resolve.

  • Drug overdose or underdose can result because of these complications and have serious and even life-threatening adverse effects.
  • Possible complications include the catheter or pump moving within the body or wearing through the skin.
  • The catheter could leak, tear, kink, or become disconnected. Additionally, inflammatory mass has been reported at the tip of the catheter, which may lead to complications, including paralysis.
  • The pump could stop because the battery has run out or because of failure of another part of the infusion system.

Please discuss the benefits and risks of this therapy with your physician.

1

Hamza M, Doleys D, Wells M, et al. Prospective study of 3-year follow-up of low dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. 2012;13:1304-1313.

2

Deer T, Chapple I, Classen A, et al. lntrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004;5:6-13.

3

Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain. 2001;5:353-361.

4

Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncot. 2002;20:4040-4049.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.